Top

Published in:

01-05-2017 | Hepatobiliary-Pancreas

Gadoxetate-enhanced MR imaging and compartmental modelling to assess hepatocyte bidirectional transport function in rats with advanced liver fibrosis

Authors: Céline Giraudeau, Benjamin Leporq, Sabrina Doblas, Matthieu Lagadec, Catherine M. Pastor, Jean-Luc Daire, Bernard E. Van Beers

Published in: European Radiology | Issue 5/2017

Abstract

Objectives

Changes in the expression of hepatocyte membrane transporters in advanced fibrosis decrease the hepatic transport function of organic anions. The aim of our study was to assess if these changes can be evaluated with pharmacokinetic analysis of the hepatobiliary transport of the MR contrast agent gadoxetate.

Methods

Dynamic gadoxetate-enhanced MRI was performed in 17 rats with advanced fibrosis and 8 normal rats. After deconvolution, hepatocyte three-compartmental analysis was performed to calculate the hepatocyte influx, biliary efflux and sinusoidal backflux rates. The expression of Oatp1a1, Mrp2 and Mrp3 organic anion membrane transporters was assessed with reverse transcription polymerase chain reaction.

Results

In the rats with advanced fibrosis, the influx and efflux rates of gadoxetate decreased and the backflux rate increased significantly (p = 0.003, 0.041 and 0.010, respectively). Significant correlations were found between influx and Oatp1a1 expression (r = 0.78, p < 0.001), biliary efflux and Mrp2 (r = 0.50, p = 0.016) and sinusoidal backflux and Mrp3 (r = 0.61, p = 0.002).

Conclusion

These results show that changes in the bidirectional organic anion hepatocyte transport function in rats with advanced liver fibrosis can be assessed with compartmental analysis of gadoxetate-enhanced MRI.

Key Points

• Expression of hepatocyte transporters is modified in rats with advanced liver fibrosis.

• Kinetic parameters at gadoxetate-enhanced MRI are correlated with hepatocyte transporter expression.

• Hepatocyte transport function can be assessed with compartmental analysis of gadoxetate-enhanced MRI.

• Compartmental analysis of gadoxetate-enhanced MRI might provide biomarkers in advanced liver fibrosis.

Available only for authorised users

International Transporter Consortium, Giacomini KM, Huang SM et al (2010) Membrane transporters in drugdevelopment. Nat Rev Drug Discov 9:215–236CrossRef

Stieger B, Heger M, de Graaf W, Paumgartner G, van Gulik T (2012) The emerging role of transport systems in liver function tests. Eur J Pharmacol 675:1–5CrossRefPubMed

Roth M, Obaidat A, Hagenbuch B (2012) OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. Br J Pharmacol 165:1260–1287CrossRefPubMedPubMedCentral

Gu X, Manautou JE (2012) Regulation of hepatic ABCC transporters by xenobiotics and in disease states. Drug Metab Rev 42:482–538CrossRef

Van Beers BE, Pastor CM, Hussain HK (2012) Primovist, Eovist: what to expect? J Hepatol 57:421–429CrossRefPubMed

Jia J, Puls D, Oswald S et al (2014) Characterization of the intestinal and hepatic uptake/efflux transport of the magnetic resonance imaging contrast agent gadolinium-ethoxylbenzyl-diethylenetriamine-pentaacetic acid. Investig Radiol 49:78–86CrossRef

Gambhir SS, Hawkins RA, Huang SC, Hall TR, Busuttil RW, Phelps ME (1989) Tracer kinetic modeling approaches for the quantification of hepatic function with technetium-99m DISIDA and scintigraphy. J Nucl Med 30:1507–1518PubMed

Araikum S, Mdaka T, Esser JD, Zuckerman M (1996) Hepatobiliary kinetics of technetium-99m-IDA analogs: quantification by linear systems theory. J Nucl Med 37:1323–1330PubMed

Peters AM (1998) Fundamental of tracer kinetics for radiologists. Br J Radiol 71:1116–1129CrossRefPubMed

10.

Nilsson H, Nordell A, Vargas R, Douglas L, Jonas E, Blomqvist L (2009) Assessment of hepatic extraction fraction and input relative blood flow using dynamic hepatocyte-specific contrast-enhanced MRI. J Magn Reson Imaging 29:1323–1331CrossRefPubMed

11.

Sourbron S, Sommer WH, Reiser MF, Zech CJ (2012) Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging. Radiology 263:874–883CrossRefPubMed

12.

Nilsson H, Blomqvist L, Douglas L, Nordell A, Jonas E (2010) Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI. HPB 12:567–576CrossRefPubMedPubMedCentral

13.

Nilsson H, Blomqvist L, Douglas L et al (2013) Gd-EOB-DTPA-enhanced MRI for the assessment of liver function and volume in liver cirrhosis. Br J Radiol 86:20120653CrossRefPubMedPubMedCentral

14.

Lagadec M, Doblas S, Giraudeau C et al (2015) Advanced fibrosis: correlation between pharmacokinetic parameters at dynamic gadoxetate-enhanced MR imaging and hepatocyte organic anion transporter expression in rat liver. Radiology 274:379–386CrossRefPubMed

15.

Haimerl M, Schlabeck M, Verloh N et al (2016) Volume-assisted estimation of liver function based on Gd-EOB-DTPA-enhanced MR relaxometry. Eur Radiol 26:1125–1133CrossRefPubMed

16.

Starkel P, Leclercq IA (2011) Animal models for the study of hepatic fibrosis. Best Pract Res Clin Gastroenterol 25:319–333CrossRefPubMed

17.

Rusinek H, Lee VS, Johnson G (2001) Optimal dose of Gd-DTPA in dynamic MR studies. Magn Reson Med 46:312–316CrossRefPubMed

18.

Braet F, Wisse E (2002) Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review. Comp Hepatol 1:1–17CrossRefPubMedPubMedCentral

19.

Van Beers BE, Materne R, Annet L et al (2003) Capillarization of the sinusoids in liver fibrosis: noninvasive assessment with contrast-enhanced MRI in the rabbit. Magn Reson Med 49:692–699CrossRefPubMed

20.

Veteläinen RL, Bennink RJ, de Bruin K, van Vliet A, van Gulik TM (2006) Hepatobiliary function assessed by 99mTc-mebrofenin cholescintigraphy in the evaluation of severity of steatosis in a rat model. Eur J Nucl Med Mol Imaging 33:1107–1114CrossRefPubMed

21.

Blouin A, Bolender RP, Weibel ER (1977) Distribution of organelles and membranes between hepatocytes and non hepatocytes in the rat liver parenchyma. A stereological study. J Cell Biol 72:441–455CrossRefPubMed

22.

Bedossa P (1994) Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 20:15–20CrossRef

23.

Peters AM, Myers MJ, Mohammadtaghi S, Mubashar M, Mathie RT (1998) Bidirectional transport of iminodiacetic organic anion analogues between plasma and hepatocyte. Eur J Nucl Med 25:766–773CrossRefPubMed

24.

Pfeifer ND, Hardwick RN, Brouwer KL (2014) Role of hepatic efflux transporters in regulating systemic and hepatocyte exposure to xenobiotics. Annu Rev Pharmacol Toxicol 54:509–535CrossRefPubMed

25.

Yoon JH, Lee JM, Paek M, Han JK, Choi BI (2016) Quantitative assessment of hepatic function: modified look-locker inversion recovery (MOLLI) sequence for T1 mapping on Gd-EOB-DTPA-enhanced liver MR imaging. Eur Radiol 26:1775–1782CrossRefPubMed

26.

Geisel D, Lüdemann L, Fröling V et al (2015) Imaging-based evaluation of liver function: comparison of 99mTc-mebrofenin hepatobiliary scintigraphy and Gd-EOB-DTPA-enhanced. MRI. Eur Radiol 25:1384–1391CrossRefPubMed

27.

Ba-Ssalamah A, Bastatai N, Wibmer A et al (2016) Hepatic gadoxetic acid uptake as a measure of liver disease: where are we? J Magn Reson Imaging, in press

28.

Materne R, Van Beers BE, Smith AM et al (2000) Non-invasive quantification of liver perfusion with dynamic computed tomography and a dual-input one-compartmental model. Clin Sci 99:517–525CrossRefPubMed

29.

Kershaw LE, Buckley DL (2006) Precision in measurements of perfusion and microvascular permeability with T1-weighted dynamic contrast-enhanced MRI. Magn Reson Med 56:986–992CrossRefPubMed

30.

Sanz-Requena R, Prats-Montalbán JM, Martí-Bonmatí L (2015) Automatic individual arterial input functions calculated from PCA outperform manual and population-averaged approaches for the pharmacokinetic modeling of DCE-MR images. J Magn Reson Imaging 42:477–487CrossRefPubMed

31.

Heye T, Merkle EM, Reiner CS et al (2013) Reproducibility of dynamic contrast-enhanced MR imaging. Part II. Comparison of intra- and interobserver variability with manual region of interest placement versus semiautomatic lesion segmentation and histogram analysis. Radiology 266:812–821CrossRefPubMed

32.

Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U (1992) Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 183:59–64CrossRefPubMed

33.

Shen Y, Goerner FL, Snyder C et al (2015) T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7 T. Investig Radiol 50:330–338CrossRef

34.

Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ (2005) Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Investig Radiol 40:715–724hCrossRef

Title: Gadoxetate-enhanced MR imaging and compartmental modelling to assess hepatocyte bidirectional transport function in rats with advanced liver fibrosis
Authors: Céline Giraudeau
Benjamin Leporq
Sabrina Doblas
Matthieu Lagadec
Catherine M. Pastor
Jean-Luc Daire
Bernard E. Van Beers
Publication date: 01-05-2017
Publisher: Springer Berlin Heidelberg
Published in: European Radiology / Issue 5/2017
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-016-4536-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Gadoxetate-enhanced MR imaging and compartmental modelling to assess hepatocyte bidirectional transport function in rats with advanced liver fibrosis

Abstract

Objectives

Methods

Results

Conclusion

Key Points

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusion

Key Points

Please log in to get access to this content

Other articles of this Issue 5/2017

Dynamic contrast enhanced MR imaging for evaluation of angiogenesis of hepatocellular nodules in liver cirrhosis in N-nitrosodiethylamine induced rat model

Volumetric MRI study of the intrauterine growth restriction fetal brain

Non-contrast 3D black blood MRI for abdominal aortic aneurysm surveillance: comparison with CT angiography

Osteonecrosis detected by whole body magnetic resonance in patients with Hodgkin Lymphoma treated by BEACOPP

Multicentre external validation of the BIMC model for solid solitary pulmonary nodule malignancy prediction

Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus 90Y-radioembolization for hepatocellular carcinoma